Dr. Kent M. Payne is distinguished as a business operator and leader in areas of sales, commercial manufacturing and product development. He has extensive executive experience in M&A as well as successfully running, start up, growth and turn around businesses. This includes both Fortune 500 and Private Equity environments. Dr. Payne combines strong business leadership, successful P&L track record, and technical background to strategically lead and grow enterprise value across Biotechnology and Pharmaceutical market segments. In addition to the United States，he has also successfully led the geographic expansion of businesses into Europe, Asia, and South America. Dr. Payne currently serves as CEO for BioDuro-Sundia, LLC (an Advent International company) and also serves as a board member for Goodwin Biotechnologies (a Signet Healthcare company).